Evidence map›Paper›PMID 25171145›Full record

ReviewNatural product reports2014

Traversing the fungal terpenome.

Maureen B Quin, Christopher M Flynn, Claudia Schmidt-Dannert

Open access · greenAbstract readReview
In one paragraph

Review in Natural product reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 356 citations in OpenAlex.

  1. Article
  2. Article
  3. Metabolic Engineering for Gibberellic Acid Production inMolecules (Basel, Switzerland) · 2026
    Review
  4. Chromosome-Level Genome Assembly and Annotation of theJournal of fungi (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Homoterpene Biosynthesis in Fungi.Angewandte Chemie (International ed. in English) · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Characterization of the Cubamyces Menziesii Terpenome.Chembiochem : a European journal of chemical biology · 2025
    Article
  14. The evolutionary history and modern diversity of triterpenoid cyclases.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome.Chembiochem : a European journal of chemical biology · 2025
    Article
  17. Article
  18. Crystal structure and catalytic mechanism of drimenol synthase, an unusual bifunctional terpene cyclase-phosphatase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Maureen B QuinUniversity of Minnesota, Dept. of Biochemistry, Molecular Biology and Biophysics, 1479 Gortner Avenue, St. Paul, MN 55108, USA.
Christopher M Flynn
Claudia Schmidt-Dannert
University of Minnesota · USUniversity of Minnesota System · US

Funding

Biosynthesis of cytotoxic sesquiterpenoids by higher basidiomycetesR01GM080299 · NIGMS · UNIVERSITY OF MINNESOTA · PI SCHMIDT-DANNERT, CLAUDIA · 2008 to 2011
$1.1M
NIGMS NIH HHS GM080299NIGMS NIH HHS R01 GM080299
6 · The paper itself

Abstract

Fungi (Ascomycota and Basidiomycota) are prolific producers of structurally diverse terpenoid compounds. Classes of terpenoids identified in fungi include the sesqui-, di- and triterpenoids. Biosynthetic pathways and enzymes to terpenoids from each of these classes have been described. These typically involve the scaffold generating terpene synthases and cyclases, and scaffold tailoring enzymes such as e.g. cytochrome P450 monoxygenases, NAD(P)+ and flavin dependent oxidoreductases, and various group transferases that generate the final bioactive structures. The biosynthesis of several sesquiterpenoid mycotoxins and bioactive diterpenoids has been well-studied in Ascomycota (e.g. filamentous fungi). Little is known about the terpenoid biosynthetic pathways in Basidiomycota (e.g. mushroom forming fungi), although they produce a huge diversity of terpenoid natural products. Specifically, many trans-humulyl cation derived sesquiterpenoid natural products with potent bioactivities have been isolated. Biosynthetic gene clusters responsible for the production of trans-humulyl cation derived protoilludanes, and other sesquiterpenoids, can be rapidly identified by genome sequencing and bioinformatic methods. Genome mining combined with heterologous biosynthetic pathway refactoring has the potential to facilitate discovery and production of pharmaceutically relevant fungal terpenoids.

Indexed as

Biological ProductsFungiTerpenesAlkyl and Aryl TransferasesMolecular StructureAlkyl and Aryl TransferasesBiological ProductsTerpenesterpene synthase

Identifiers

PMID25171145
PMCPMC4167380
OpenAlexW1994525974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.